Mesothelioma Cancer Resources Blog

Mesothelioma, often referred to as an orphan disease due to the minimal amount of research dedicated to finding a cure, now has several tissue banks and data warehouses for researchers to access when studying the disease. These databases and biospeciman registries are designed and offered to advance the knowledge and understanding of mesothelioma and to …

Power plant workers can breathe easier now that the Environmental Protection Agency issued a consent decree to allow for the passage of new rules aimed at reducing toxic emissions of soot, mercury, and other chemicals from coal-fired and oil-burning power plants. The EPA was sued by a coalition of public health and environmental groups claiming …

In September the National Institutes of Health announced the winners of their awards designated to encourage high-risk research and innovation. They have awarded $348 million to “encourage investigators to explore bold ideas that have the potential to catapult fields forward and speed the translation of research into improved health.” The awards fall under three research …

Hawaii is known for many things: surfing, beautiful beaches, pineapples, and now, cancer research. Michele Carbone, MD, PhD (Human Pathology), has recently been named director of the Cancer Research Center of Hawaii. He began his three-year term September 1, 2009, having previously served as the Center’s interim director since December 2008. Prior to joining the …

Belluck & Fox, one of the leading law firms in the United States representing individuals with asbestos and mesothelioma claims, won a $1.5 million verdict and $750,000 in punitive damages against Fisher Controls International. Belluck & Fox represented the family of Ronald Drabczyk who died from mesothelioma after being exposed to asbestos while on the …

Simcere Pharmaceutical Group, a Chinese pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals, has joined forces with OSI Pharmaceuticals, Inc. of the United States, to develop, manufacture, and market its KDR/Kit inhibitor OSI-930 in China. OSI, based in Long Island, NY, specialized in the discovery and development of …

Study: Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma Start Date: January 2009 End Date: January 2020 Recruiting Contacts Andrea Foster, 416-946-4501 ext 5010, Andrea.Foster@Uhn.on.ca Jennifer Hornby, BSc CCRP 416-340-4857, Jennifer.Hornby@uhn.on.ca Information The University Health Network of Toronto is currently recruiting participants for a clinical trial using a combination of Pemetrexed …

The FirstHealth of the Carolinas, a private, not-for-profit health care network serving the mid-Carolinas, Clinical Trials Department has partnered with the Wake Forest School of Medicine to promote participation in a research study investigating the development and progression of asbestos-related lung diseases and cancers. The study is requesting participants that have been diagnosed with mesothelioma …

Mesothelioma patients know that the best treatment they can receive is offered at cancer centers that have a mesothelioma program staffed with physicians and medical teams that specialize in the treatment of their disease. Many times patients find that while the treatment required is available, the hospital or facility can be hundreds or even thousands …

Senator Patty Murray (WA) and Congresswoman Betty McCollum (MN-4) have introduced resolutions in Congress designating September 26th as “National Mesothelioma Awareness Day.” Mesothelioma Awareness Day was introduced by the Mesothelioma Applied Research Foundation (MARF) over 4 years ago and has been supported by volunteers. Chris Hahn, Executive Director of MARF, hopes that now “mesothelioma will …